Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer
Background Neoadjuvant or adjuvant chemotherapy confers a modest benefit over surgery
alone for resectable non–small-cell lung cancer (NSCLC). In early-phase trials, nivolumab …
alone for resectable non–small-cell lung cancer (NSCLC). In early-phase trials, nivolumab …
European guidelines for the surgical management of pure ground-glass opacities and part-solid nodules: Task Force of the European Association of Cardio-Thoracic …
Pulmonary nodules are often encountered by respiratory physicians, radiologists and
thoracic surgeons alike. The European Association of Cardio-Thoracic Surgery and the …
thoracic surgeons alike. The European Association of Cardio-Thoracic Surgery and the …
[HTML][HTML] Enhanced recovery after surgery and chest tube management
TJP Batchelor - Journal of Thoracic Disease, 2023 - ncbi.nlm.nih.gov
This review documents the relationships between enhanced recovery after surgery (ERAS)
pathways, chest tube management and patient outcomes following lung resection surgery …
pathways, chest tube management and patient outcomes following lung resection surgery …
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage …
Background At the first interim analysis of the KEYNOTE-671 trial, adding perioperative
pembrolizumab to neoadjuvant chemotherapy significantly improved event-free survival in …
pembrolizumab to neoadjuvant chemotherapy significantly improved event-free survival in …
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: staging and multidisciplinary management of patients with early-stage non …
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document:
Staging and multidisciplinary management of patients with early-stage non–small cell lung …
Staging and multidisciplinary management of patients with early-stage non–small cell lung …
Minimally invasive surgery in non-small cell lung cancer: where do we stand?
L Berzenji, W Wen, S Verleden, E Claes… - Cancers, 2023 - mdpi.com
Simple Summary In the last twenty years, minimally invasive surgery (MIS) has radically
changed the surgical landscape. In the field of thoracic surgery, approaches such as video …
changed the surgical landscape. In the field of thoracic surgery, approaches such as video …
[HTML][HTML] Perioperative cardiovascular pathophysiology in patients undergoing lung resection surgery: a narrative review
B Shelley, A Glass, T Keast, J McErlane… - British Journal of …, 2023 - Elsevier
Although thoracic surgery is understood to confer a high risk of postoperative respiratory
complications, the substantial haemodynamic challenges posed are less well appreciated …
complications, the substantial haemodynamic challenges posed are less well appreciated …
[HTML][HTML] Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab …
VW Rusch, A Nicholas, GA Patterson, SN Waqar… - The Journal of thoracic …, 2023 - Elsevier
Objective Multimodality treatment for resectable non–small cell lung cancer has long
remained at a therapeutic plateau. Immune checkpoint inhibitors are highly effective in …
remained at a therapeutic plateau. Immune checkpoint inhibitors are highly effective in …
Association between surgical quality metric adherence and overall survival among US veterans with early-stage non–small cell lung cancer
Importance Surgical resection remains the preferred treatment for functionally fit patients
diagnosed with early-stage non–small cell lung cancer (NSCLC). Process-based …
diagnosed with early-stage non–small cell lung cancer (NSCLC). Process-based …
Which extent of surgical resection thoracic surgeons would choose if they were diagnosed with an early-stage lung cancer: a European survey
The recent publication of 3 randomized trials has established segmentectomy as a valuable
alternative to lobectomy in peripheral lymph node-negative stage IA1 and IA2 non-small-cell …
alternative to lobectomy in peripheral lymph node-negative stage IA1 and IA2 non-small-cell …